| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.14 | 6e-06 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0003 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.41 | 0.0004 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.14 | 0.0008 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0009 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.001 |